Patents by Inventor Powell Richards

Powell Richards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5116597
    Abstract: Disclosed herein are a method and kit for the preparation of .sup.99m Tc labeled red blood cells using whole blood in a closed sterile system containing stannous tin in a form such that it will enter the red blood cells and be available therein for reduction of technetium.
    Type: Grant
    Filed: April 18, 1988
    Date of Patent: May 26, 1992
    Assignee: Associated Universities, Inc.
    Inventors: Suresh C. Srivastava, John W. Babich, Rita Straub, Powell Richards
  • Patent number: 4755375
    Abstract: Disclosed herein are a method and kit for the preparation of .sup.99m Tc labeled red blood cells using whole blood in a closed sterile system containing stannous tin in a form such that it will enter the red blood cells and be available therein for the reduction of technetium.
    Type: Grant
    Filed: April 17, 1986
    Date of Patent: July 5, 1988
    Assignee: Associated Universities, Inc.
    Inventors: Suresh C. Srivastava, John W. Babich, Rita Straub, Powell Richards
  • Patent number: 4707322
    Abstract: Beryllium-7 labeled carbon particles made from the proton irradiation of carbon materials, preferably from dry carbon black are disclosed. Such particles are useful as gamma emitting radiotracers.
    Type: Grant
    Filed: April 29, 1985
    Date of Patent: November 17, 1987
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Powell Richards, Leonard F. Mausner, Thomas F. Prach
  • Patent number: 4533541
    Abstract: The radiopharmaceutical reagents of this invention and the class of Tin-117m radiopharmaceuticals are therapeutic and diagnostic agents that incorporate gamma-emitting nuclides that localize in bone after intravenous injection in mammals (mice, rats, dogs, and rabbits). Images reflecting bone structure or function can then be obtained by a scintillation camera that detects the distribution of ionizing radiation emitted by the radioactive agent. Tin-117m-labeled chelates of stannic tin localize almost exclusively in cortical bone. Upon intravenous injection of the reagent, the preferred chelates are phosphonate compounds, preferable, PYP, MDP, EHDP, and DTPA. This class of reagents is therapeutically and diagnostically useful in skeletal scintigraphy and for the radiotherapy of bone tumors and other disorders.
    Type: Grant
    Filed: August 25, 1983
    Date of Patent: August 6, 1985
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Suresh C. Srivastava, George E. Meinken, Powell Richards
  • Patent number: 4500508
    Abstract: Lymphocytes labelled with .beta.-emitting radionuclides are therapeutically useful, particularly for lymphoid ablation. They are prepared by incubation of the lymphocytes with the selected radionuclide-oxine complex.
    Type: Grant
    Filed: May 3, 1983
    Date of Patent: February 19, 1985
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Suresh C. Srivastava, Rashid A. Fawwaz, Powell Richards
  • Patent number: 4448762
    Abstract: A novel Ruthenium-transferrin complex, prepared by reacting iron-free human transferrin dissolved in a sodium acetate solution at pH 7 with ruthenium by heating at about 40.degree. C. for about 2 hours, and purifying said complex by means of gel chromotography with pH 7 sodium acetate as eluent. The mono- or di-metal complex produced can be used in nuclear medicine in the diagnosis and/or treatment of tumors and abscesses. Comparative results with Ga-67-citrate, which is the most widely used tumor-localizing agent in nuclear medicine, indicate increased sensitivity of detection and greater tumor uptake with the Ru-transferrin complex.
    Type: Grant
    Filed: November 3, 1980
    Date of Patent: May 15, 1984
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Powell Richards, Suresh C. Srivastava, George E. Meinken
  • Patent number: 3988429
    Abstract: A method and sample kit for the preparation of .sup.99m Tc-labeled red blood cells in a closed, sterile system. A partially evacuated tube, containing a freeze-dried stannous citrate formulation with heparin as an anticoagulant, allows whole blood to be automatically drawn from the patient. The radioisotope is added at the end of the labeling sequence to minimize operator exposure. Consistent 97% yields in 20 minutes are obtained with small blood samples. Freeze-dried kits have remained stable after five months.
    Type: Grant
    Filed: April 16, 1975
    Date of Patent: October 26, 1976
    Assignee: The United States of America as represented by the United States Energy Research and Development Administration
    Inventors: Powell Richards, Terry D. Smith